secwatch.observer — SEC 8-K summary
======================================

Issuer:     Werewolf Therapeutics, Inc. (HOWL)
CIK:        0001785530
Form:       8-K
Filed at:   2022-06-07T23:59:59+00:00
Accession:  0001193125-22-169285
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Werewolf Therapeutics announces annual meeting voting results; directors elected and auditor ratified
--------------------------------------------------------------------------------

- Stockholders elected Briggs Morrison and Michael Sherman as Class I directors for three-year terms ending in 2025.
- Ratification of Deloitte & Touche as auditor for FY2022 passed with 23,945,185 votes for, 1,694 against, 12 abstain.
- Broker non-votes on director elections totaled 3,626,970.
- No other material proposals were presented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785530/000119312522169285/0001193125-22-169285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785530/000119312522169285/d286266d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-169285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer